These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 21702248)
1. Escitalopram related erectile dysfunction and spontaneous ejaculation during micturition. Belli H; Aslaner D; Ural C; Vardar MK; Yesilyurt S; Gul ES West Indian Med J; 2010 Dec; 59(6):715-6. PubMed ID: 21702248 [No Abstract] [Full Text] [Related]
2. The effects of citalopram and fluoxetine on sexual behavior in healthy men: evidence of delayed ejaculation and unaffected sexual desire. A randomized, placebo-controlled, double-blind, double-dummy, parallel group study. Madeo B; Bettica P; Milleri S; Balestrieri A; Granata AR; Carani C; Rochira V J Sex Med; 2008 Oct; 5(10):2431-41. PubMed ID: 18410297 [TBL] [Abstract][Full Text] [Related]
15. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study. Lin YT; Lu TS; Hansen RA; Wang CC Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037 [TBL] [Abstract][Full Text] [Related]
16. [Sexsomnia during treatment with a selective serotonin reuptake inhibitor]. Krol DG Tijdschr Psychiatr; 2008; 50(11):735-9. PubMed ID: 18991234 [TBL] [Abstract][Full Text] [Related]
17. Escitalopram-Induced Rash. Prabhakar D; Sablaban I Prim Care Companion CNS Disord; 2019 Jan; 21(1):. PubMed ID: 30806996 [No Abstract] [Full Text] [Related]
18. Pharmacological treatment for premature ejaculation. Richardson D; Goldmeier D Int J STD AIDS; 2005 Oct; 16(10):709-11. PubMed ID: 16212722 [TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitors for premature ejaculation: review of erectile and ejaculatory side effects. Lasker GF; Halis F; Gokce A Curr Drug Saf; 2014; 9(2):118-26. PubMed ID: 24446888 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study. McMahon CG; Giuliano F; Dean J; Hellstrom WJ; Bull S; Tesfaye F; Sharma O; Rivas DA; Aquilina JW J Sex Med; 2013 Sep; 10(9):2312-25. PubMed ID: 23845016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]